Send me a link:

*Text messaging rates may apply.

 Dow Up0.36% Nasdaq Up0.71%

Generex Biotechnology Corp. (GNBT)

-Other OTC
0.02 Down 0.00(0.87%) Jul 22, 3:39PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJul 31, 2013Jul 31, 2012Jul 31, 2011
Total Revenue -   29   292  
Cost of Revenue -  11  156  
Gross Profit -   18   136  
Operating Expenses
Research Development2,193  4,987  10,250  
Selling General and Administrative3,937  5,054  14,419  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (6,129) (10,024) (24,533)
Income from Continuing Operations
Total Other Income/Expenses Net(1,895)1,126  3,066  
Earnings Before Interest And Taxes(8,024)(8,898)(21,467)
Interest Expense530  593  209  
Income Before Tax(8,554)(9,490)(21,676)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(8,554)(9,490)(21,676)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (8,554) (9,490) (21,676)
Preferred Stock And Other Adjustments(1,722)(377)(766)
Net Income Applicable To Common Shares (10,277) (9,867) (22,442)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.